Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9137522 | 1.00 | SMN1; SMN2 (0.52) | SMN1; SMN2MEN1KMT2ATDP1SOAT1 | |
| SCHEMBL9137012 | 1.00 | SMN1; SMN2 (0.52) | SMN1; SMN2MEN1KMT2ATDP1SOAT1 | |
| SCHEMBL282144 | 0.88 | SOAT1 (0.54) | SMN1; SMN2SOAT1 | |
| SCHEMBL9050595 | 0.88 | SOAT1 (0.54) | SMN1; SMN2SOAT1 | |
| SCHEMBL9048615 | 0.88 | SOAT1 (0.54) | SMN1; SMN2SOAT1 | |
| SCHEMBL9048730 | 0.88 | SOAT1 (0.54) | SMN1; SMN2SOAT1 | |
| SCHEMBL6941060 | 0.88 | SOAT1 (0.54) | SMN1; SMN2SOAT1 | |
| SCHEMBL9049272 | 0.88 | SOAT1 (0.54) | SMN1; SMN2SOAT1 | |
| SCHEMBL9050107 | 0.88 | SOAT1 (0.54) | SMN1; SMN2SOAT1 | |
| SCHEMBL9136794 | 0.87 | SMN1; SMN2 (0.59) | SMN1; SMN2MEN1KMT2ATDP1SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5416212-A | Antilipemic agents, enzyme inhibitors and anticholesterol agents | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1995-05-16 | — | — | US | disclosed |
| EP-0619312-A1 | ANILIDE DERIVATIVE | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1994-10-12 | — | — | EP | disclosed |